Eyenovia Reports Third Quarter 2019 Financial Results
13 nov. 2019 16h05 HE
|
Eyenovia, Inc.
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results
31 oct. 2019 08h30 HE
|
Eyenovia, Inc.
NEW YORK, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline
29 oct. 2019 16h05 HE
|
Eyenovia, Inc.
Defers development activities of MicroProst and MicroTears Company to host conference call on Tuesday, October 29, 2019 at 5:00 pm ET NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc....
Eyenovia to Participate in Multiple Upcoming Medical Meetings
02 oct. 2019 08h30 HE
|
Eyenovia, Inc.
NEW YORK, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia to Present at Two Upcoming Investor Conferences
03 sept. 2019 08h30 HE
|
Eyenovia, Inc.
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Reports Second Quarter 2019 Financial Results
12 août 2019 16h05 HE
|
Eyenovia, Inc.
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results
06 août 2019 08h30 HE
|
Eyenovia, Inc.
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
16 juil. 2019 16h05 HE
|
Eyenovia, Inc.
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Announces Closing of Public Offering
15 juil. 2019 16h30 HE
|
Eyenovia, Inc.
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Prices Public Offering of Common Stock
11 juil. 2019 09h00 HE
|
Eyenovia, Inc.
NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...